Nazar (Naphazoline Nitrate)

Naphazoline nitrate acts as a selective alpha‑adrenergic agonist. When applied to the nasal mucosa, it triggers vasoconstriction of the small blood vessels, reducing swelling and allowing air to flow more freely through the nose.

The appropriate dose of Nazar is determined by the prescribing healthcare professional. Typically, a few sprays per nostril are used, but the exact number and frequency should follow the prescriber’s instructions and the product label.

Safety data for naphazoline nitrate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Nazar to weigh potential benefits against risks.

To order Nazar, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nazar’s active ingredient, naphazoline nitrate, provides rapid vasoconstriction similar to other imidazoline decongestants like oxymetazoline. Compared with phenylephrine‑based sprays, naphazoline often offers a slightly longer duration of action but shares the same caution regarding limited‑duration use to prevent rebound congestion.

Store Nazar at room temperature, ideally below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Nazar is applied topically to each nostril using the spray pump. The user should tilt the head slightly forward, insert the tip into the nostril, and press the pump to deliver the recommended number of sprays, avoiding direct contact with the nasal mucosa.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, elevated blood pressure, tachycardia, and rare cardiac arrhythmias. Patients with cardiovascular disease, hypertension, or glaucoma should use Nazar only under medical supervision.

Nazar should not be used by individuals with known hypersensitivity to naphazoline nitrate or any formulation components, patients with severe hypertension, narrow‑angle glaucoma, or those who have used other nasal decongestants for more than three consecutive days without medical advice.